|
|
 |
| |
|
Home > Drug Companies > Taro Pharmaceuticals U.S.A., Inc.
Taro Pharmaceuticals U.S.A., Inc.
A drug manufacturer is a business entity engaged in making, assembling, processing or modifying devices, or mixing, producing or preparing drugs in dosage forms by encapsulating, entableting or other process, or packaging, repackaging or otherwise changing the container, wrapper or label of any package containing a drug or device in furtherance of the distribution of the drug or device from the original place of manufacture to the person who makes final delivery or sale to the ultimate consumer.
Israeli pharmacists and American physicians, led by the Levitt and Moros families, collaborate to establish Taro Pharmaceutical Industries Ltd. The company’s name taken from the Hebrew words for pharmaceutical industry reveals the dream of the founders. They believe that Taro can play a role in helping Israel, then just two years old, poor in natural resources, but rich in intellectual capital, to develop a world class pharmaceutical industry.
Taro entered the U.S. market in 1988, after establishing its Canadian subsidiary in 1984 and receiving approval of its first topical product in the United States. The U.S. has become Taro’s largest market, accounting for more than 80percent of their global sales. Their proprietary and generic U.S. products are both prescription and over the counter medications, sold in Taro label and private label store brand.
They include topical dermatological prescription pharmaceuticals creams, ointments, gels a category in which Taro is an acknowledged leader, as well as a growing line of oral dose drugs tablets and capsules used primarily in cardiovascular and neurological disorders. Taro U.S.A. maintains its own distribution facilities so that their U.S. customers, who include the largest drugstore chains and wholesalers, are assured of a continuous supply of Taro products. Taro's first U.S. research operations were established in 2003.
Back to Drug Companies
|
|
|
|
|
|
|
|